Epigenetic heterogeneity of B-cell lymphoma: DNA methylation, gene expression and chromatin states

Genes

Volumn 6, Issue 3, 2015, Pages 812-840

  Hopp, Lydia ^a   Löffler Wirth, Henry ^a   Binder, Hans ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Epigenetic reprogramming; Gene expression; Germinal center; High dimensional data portraying; Machine learning; Promoter methylation; Stemness

Indexed keywords

DNA; MYC PROTEIN; POLYCOMB REPRESSIVE COMPLEX 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR SUZ12; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CARCINOGENESIS; CELL MATURATION; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DNA METHYLATION; DNA MICROARRAY; EPIGENETICS; EZH2 GENE; FOLLICULAR LYMPHOMA; GENE DISRUPTION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE TARGETING; LARGE CELL LYMPHOMA; MANTLE CELL LYMPHOMA; MULTIPLE MYELOMA; ONCOGENE C MYC; PRC2 GENE; SUZ12 GENE;

EID: 84941210381     PISSN: None     EISSN: 20734425     Source Type: Journal    
DOI: 10.3390/genes6030812     Document Type: Article

References (47)

1. Alizadeh, A.A.; Eisen, M.B.; Davis, R.E.; Ma, C.; Lossos, I.S.; Rosenwald, A.; Boldrick, J.C.; Sabet, H.; Tran, T.; Yu, X.; et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403, 503-511.
2. Dave, S.S.; Fu, K.; Wright, G.W.; Lam, L.T.; Kluin, P.; Boerma, E.-J.; Greiner, T.C.; Weisenburger, D.D.; Rosenwald, A.; Ott, G.; et al. Molecular diagnosis of Burkitt's lymphoma. N. Engl. J. Med. 2006, 354, 2431-2442.
3. Lenz, G.; Wright, G.W.; Emre, N.C.T.; Kohlhammer, H.; Dave, S.S.; Davis, R.E.; Carty, S.; Lam, L.T.; Shaffer, A.L.; Xiao, W.; et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc. Natl. Acad. Sci. USA 2008, 105, 13520-13525.
4. Hummel, M.; Bentink, S.; Berger, H.; Klapper, W.; Wessendorf, S.; Barth, T.F.E. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N. Engl. J. Med. 2006, 354, 2419-2430.
5. Hopp, L.; Lembcke, K.; Binder, H.; Wirth, H. Portraying the expression landscapes of B-Cell lymphoma-intuitive detection of outlier samples and of molecular subtypes. Biology 2013, 2, 1411-1437.
6. Wirth-Loeffler, H.; Hopp, L.; Kreuz, M.; Siebert, R.; Loeffler, M.; Binder, H. A holistic view on the expression landscape of Germinal center-derived B-cell lymphomas. Unpublished work, 2015.
7. Shaknovich, R.; Cerchietti, L.; Tsikitas, L.; Kormaksson, M.; De, S.; Figueroa, M.E.; Ballon, G.; Yang, S.N.; Weinhold, N.; Reimers, M.; et al. DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation. Blood 2011, 118, 3559-3569.
8. Martín-Subero, J.I.; Kreuz, M.; Bibikova, M.; Bentink, S.; Ammerpohl, O.; Wickham-Garcia, E.; Siebert, R. New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood 2009, 113, 2488-2497.
9. Jiang, Y.; Melnick, A. The epigenetic basis of diffuse large B-Cell lymphoma. Semin. Hematol. 2015, 52, 86-96.
10. Wang, G.G.; Konze, K.D.; Tao, J. Polycomb genes, miRNA, and their deregulation in B-cell malignancies. Blood 2015, 125, 1217-1225.
11. Non-Hodgkin Lymphoma Statistics. Available online: http://www.cancerresearchuk.org/cancerinfo/ cancerstats/types/nhl (accessed on 20 August 2015).
12. Hopp, L.; Wirth, H.; Fasold, M.; Binder, H. Portraying the expression landscapes of cancer subtypes: A glioblastoma multiforme and prostate cancer case study. Syst. Biomed. 2013, doi:10.4161/sysb.25897.
13. Reifenberger, G.; Weber, R.G.; Riehmer, V.; Kaulich, K.; Willscher, E.; Wirth, H.; Gietzelt, J.; Hentschel, B.; Westphal, M.; Simon, M.; et al. Molecular characterization of long-term survivors of glioblastoma using genome-and transcriptome-wide profiling. Int. J. Cancer 2014, 135, 1822-1831.
14. Weller, M.; Weber, R.; Willscher, E.; Riehmer, V.; Hentschel, B.; Kreuz, M.; Reifenberger, G.; Felsberg, J.; Beyer, U.; Löffler-Wirth, H.; et al. Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome-and transcriptome-wide profiling improves stratification of prognostically distinct patient groups. Acta Neuropathol. 2015, 129, 679-693.
15. Martin-Subero, J.I.; Ammerpohl, O.; Bibikova, M.; Wickham-Garcia, E.; Agirre, X.; Alvarez, S.; Brüggemann, M.; Bug, S.; Calasanz, M.J.; Deckert, M. A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms. PLoS ONE 2009, 4, e6986.
16. Wirth, H.; Loeffler, M.; von Bergen, M.; Binder, H. Expression cartography of human tissues using self organizing maps. BMC Bioinf. 2011, doi:10.1186/1471-2105-12-306.
17. Wirth, H.; von Bergen, M.; Binder, H. Mining SOM expression portraits: Feature selection and integrating concepts of molecular function. BioData Min. 2012, doi:10.1186/1756-0381-5-18.
18. Wirth-Loeffler, H.; Kalcher, M.; Binder, H. OposSOM: R-package for high-dimensional portraying of genome-wide expression landscapes on bioconductor. Bioinformatics 2015, doi:10.1093/bioinformatics/btv342.
19. Toronen, P.; Ojala, P.; Marttinen, P.; Holm, L. Robust extraction of functional signals from gene set analysis using a generalized threshold free scoring function. BMC Bioinf. 2009, doi:10.1186/1471-2105-10-307.
20. De, S.; Shaknovich, R.; Riester, M.; Elemento, O.; Geng, H.; Kormaksson, M.; Jiang, Y.; Woolcock, B.; Johnson, N.; Polo, J.M. Aberration in DNA methylation in B-Cell lymphomas has a complex origin and increases with disease severity. PLoS Genet. 2013, 9, e1003137.
21. Chambwe, N.; Kormaksson, M.; Geng, H.; De, S.; Michor, F.; Johnson, N.A.; Morin, R.D.; Scott, D.W.; Godley, L.A.; Gascoyne, R.D. Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes. Blood 2014, 123, 1699-1708.
22. Binder, H.; Wirth, H.; Arakelyan, A.; Lembcke, K.; Tiys, E.S.; Ivanishenko, V.; Kolchanov, N.A.; Kononikhin, A.; Popov, I.; Nikolaev, E.N.; et al. Time-course human urine proteomics in space-flight simulation experiments. BMC Genomics 2014, doi:10.1186/1471-2164-15-S12-S2.
23. Walker, E.; Manias, J.L.; Chang, W.Y.; Stanford, W.L. PCL2 modulates gene regulatory networks controlling self-renewal and commitment in embryonic stem cells. Cell Cycle 2011, 10, 45-51.
24. Ang, P.; Loh, M.; Liem, N.; Lim, P.; Grieu, F.; Vaithilingam, A.; Platell, C.; Yong, W.P.; Iacopetta, B.; Soong, R. Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features. BMC Cancer 2010, doi:10.1186/1471-2407-10-227.
25. Teschendorff, A.E.; Liu, X.; Caren, H.; Pollard, S.M.; Beck, S.; Widschwendter, M.; Chen, L. The dynamics of DNA methylation covariation patterns in carcinogenesis. PLoS Comput. Biol. 2014, 10, e1003709.
26. Christensen, B.C.; Smith, A.A.; Zheng, S.; Koestler, D.C.; Houseman, E.A.; Marsit, C.J.; Wiemels, J.L.; Nelson, H.H.; Karagas, M.R.; Wrensch, M.R.; et al. DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma. J. Natl. Cancer Instit. 2011, 103, 143-153.
27. Kim, Y.H.; Girard, L.; Giacomini, C.P.; Wang, P.; Hernandez-Boussard, T.; Tibshirani, R.; Minna, J.D.; Pollack, J.R. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification. Oncogene 2005, 25, 130-138.
28. Sturm, D.; Witt, H.; Hovestadt, V.; Khuong-Quang, D.-A.; Jones, D.T.W.; Konermann, C.; Konermann, C.; Pfaff, E.; Tönjes, M.; Sill, M.; Bender, S.; et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 2012, 22, 425-437.
29. Bentink, S.; Wessendorf, S.; Schwaenen, C.; Rosolowski, M.; Klapper, W.; Rosenwald, A.; Ott, G.; Banham, A.H.; Berger, H.; Feller, A.C.; et al. Pathway activation patterns in diffuse large B-cell lymphomas. Leukemia 2008, 22, 1746-1754.
30. Wang, G.G.; Song, J.; Wang, Z.; Dormann, H.L.; Casadio, F.; Li, H.; Allis, C.D.; Luo, J.L.; Patel, D.J. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger. Nature 2009, 459, 847-851.
31. Laffaire, J.; Everhard, S.; Idbaih, A.; Crinière, E.; Marie, Y.; de Reyniès, A.; Schiappa, R.; Mokhtari, K.; Hoang-Xuan, K.; Sanson, M.; et al. Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis. Neuro. Oncol. 2011, 13, 84-98.
32. Hebenstreit, D.; Fang, M.; Gu, M.; Charoensawan, V.; van Oudenaarden, A.; Teichmann, S.A. RNA sequencing reveals two major classes of gene expression levels in metazoan cells. Mol. Syst. Biol. 2011, 7, doi:10.1038/msb.2011.28.
33. The ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489, 57-74.
34. Lee, T.I.; Jenner, R.G.; Boyer, L.A.; Guenther, M.G.; Levine, S.S.; Kumar, R.M.; Chevalier, B.; Johnstone, S.E.; Cole, M.F.; Isono, K.; et al. Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells. Cell 2006, 125, 301-313.
35. Teschendorff, A.E.; West, J.; Beck, S. Age-associated epigenetic drift: implications, and a case of epigenetic thrift? Hum. Mol. Genet. 2013, 22, R7-R15.
36. Noushmehr, H.; Weisenberger, D.J.; Diefes, K.; Phillips, H.S.; Pujara, K.; Berman, B.P.; Pan, F.; Pelloski, C.E.; Sulman, E.P.; Bhat, K.P.; et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 2010, 17, 510-522.
37. Kondo, Y.; Shen, L.; Cheng, A.S.; Ahmed, S.; Boumber, Y.; Charo, C.; Yamochi, T.; Urano, T.; Furukawa, K.; Kwabi-Addo, B. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat. Genet. 2008, 40, 741-750.
38. Hendricks, K.B.; Shanahan, F.; Lees, E. Role for BRG1 in cell cycle control and tumor suppression. Mol. Cell. Biol. 2004, 24, 362-376.
39. Velichutina, I.; Shaknovich, R.; Geng, H.; Johnson, N.A.; Gascoyne, R.D.; Melnick, A.M.; Elemento, O. EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis. Blood 2010, 116, 5247-5255.
40. Béguelin, W.; Popovic, R.; Teater, M.; Jiang, Y.; Bunting, K.L.; Rosen, M.; Shen, H.; Yang, S.N.; Wang, L.; Ezponda, T.; et al. EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation. Cancer Cell 2013, 23, 677-692.
41. Ernst, J.; Kellis, M. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat. Biotech. 2010, 28, 817-825.
42. Ernst, J.; Kheradpour, P.; Mikkelsen, T.S.; Shoresh, N.; Ward, L.D.; Epstein, C.B.; Zhang, X.; Wang, L.; Issner, R.; Coyne, M.; et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011, 473, 43-49.
43. Dave, S.S.; Wright, G.; Tan, B.; Rosenwald, A.; Gascoyne, R.D.; Chan, W.C.; Fisher, R.I.; Braziel, R.M.; Rimsza, L.M.; Grogan, T.M.; et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N. Engl. J. Med. 2004, 351, 2159-2169.
44. Victora, G.D.; Dominguez-Sola, D.; Holmes, A.B.; Deroubaix, S.; Dalla-Favera, R.; Nussenzweig, M.C. Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas. Blood 2012, 120, 2240-2248.
45. Dominguez-Sola, D.; Victora, G.D.; Ying, C.Y.; Phan, R.T.; Saito, M.; Nussenzweig, M.C.; Dalla-Favera, R. The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry. Nat. Immunol. 2012, 13, 1083-1091.
46. De Silva, N.S.; Klein, U. Dynamics of B cells in germinal centres. Nat. Rev. Immunol. 2015, 15, 137-148.
47. Voigt, P.; Tee, W.-W.; Reinberg, D. A double take on bivalent promoters. Genes Dev. 2013, 27, 1318-1338.